GravesT. Ondansetron: A new entity in emesis control. DICP Ann Pharmacother1990; 24 (suppl): S51–4.
2.
MartyMPouillartPSchollS., Comparison of the 5-hydroxytryptamine3 (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis. N Engl J Med1990; 322: 816–21.
3.
De MulderPHMSeynaeveCVermorkenJB, Ondansetron compared with high dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting. A multicenter, randomized, double blind, cross-over study. Ann Intern Med1990; 113: 834–40.
4.
HawthornJCunninghamD. Dexamethasone can potentiate the antiemetic action of a 5HT3 receptor antagonist on cyclophosphamide induced vomiting in the ferret. Br J Cancer1990; 61: 56–60.
5.
LeakREWoodfordJD. Pharmaceutical development of ondansetron injection. Eur J Cancer Clin Oncol1989; 25: S67–9.
6.
FNA [Formulary of Dutch Pharmacists]. Den Haag, The Netherlands: KNMP [Royal Dutch Association for Advancement of Pharmacy], 1979: 120.